A detailed history of Steward Partners Investment Advisory, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 629 shares of IONS stock, worth $26,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares
629
Previous 723 13.0%
Holding current value
$26,883
Previous $31,000 6.45%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$36.45 - $47.7 $3,426 - $4,483
-94 Reduced 13.0%
629 $29,000
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $10,171 - $12,959
242 Added 50.31%
723 $31,000
Q4 2023

Feb 12, 2024

SELL
$43.39 - $51.63 $1,084 - $1,290
-25 Reduced 4.94%
481 $24,000
Q3 2023

Nov 13, 2023

BUY
$38.5 - $47.13 $9,240 - $11,311
240 Added 90.23%
506 $22,000
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $2,014 - $2,513
-58 Reduced 17.9%
266 $10,000
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $369 - $453
11 Added 3.51%
324 $11,000
Q4 2022

Feb 15, 2023

SELL
$37.12 - $46.52 $853 - $1,069
-23 Reduced 6.85%
313 $11,000
Q3 2022

Nov 10, 2022

SELL
$36.54 - $48.66 $950 - $1,265
-26 Reduced 7.18%
336 $15,000
Q1 2022

May 02, 2022

SELL
$29.88 - $37.04 $10,248 - $12,704
-343 Reduced 48.65%
362 $13,000
Q4 2021

Feb 08, 2022

SELL
$25.61 - $35.1 $67,892 - $93,050
-2,651 Reduced 78.99%
705 $21,000
Q3 2021

Nov 12, 2021

BUY
$33.54 - $40.55 $8,183 - $9,894
244 Added 7.84%
3,356 $113,000
Q2 2021

Aug 13, 2021

SELL
$34.54 - $47.25 $146,104 - $199,867
-4,230 Reduced 57.61%
3,112 $124,000
Q1 2021

May 14, 2021

BUY
$42.51 - $63.78 $83,107 - $124,689
1,955 Added 36.29%
7,342 $330,000
Q4 2020

Feb 11, 2021

BUY
$45.3 - $60.27 $10,645 - $14,163
235 Added 4.56%
5,387 $305,000
Q3 2020

Oct 30, 2020

BUY
$47.45 - $62.95 $7,829 - $10,386
165 Added 3.31%
5,152 $244,000
Q2 2020

Aug 06, 2020

BUY
$46.85 - $61.05 $58,094 - $75,702
1,240 Added 33.09%
4,987 $294,000
Q3 2019

Oct 30, 2019

BUY
$59.06 - $72.15 $33,959 - $41,486
575 Added 18.13%
3,747 $224,000
Q2 2019

Jul 25, 2019

SELL
$62.09 - $86.14 $10,431 - $14,471
-168 Reduced 5.03%
3,172 $203,000
Q1 2019

Apr 30, 2019

BUY
$52.92 - $81.17 $176,752 - $271,107
3,340 New
3,340 $271,000
Q4 2018

Jan 15, 2019

SELL
$43.37 - $59.54 $145,983 - $200,411
-3,366 Closed
0 $0
Q3 2018

Oct 23, 2018

SELL
$42.88 - $53.7 $5,360 - $6,712
-125 Reduced 3.58%
3,366 $174,000
Q2 2018

Jul 20, 2018

BUY
$40.53 - $50.7 $2,188 - $2,737
54 Added 1.57%
3,491 $145,000
Q1 2018

Apr 20, 2018

SELL
$44.08 - $55.05 $77,624 - $96,943
-1,761 Reduced 33.88%
3,437 $151,000
Q4 2017

Jan 19, 2018

BUY
$50.3 - $64.39 $162,116 - $207,528
3,223 Added 163.19%
5,198 $261,000
Q2 2017

Nov 22, 2017

BUY
N/A
1,690 Added 592.98%
1,975 $100,000
Q1 2017

Nov 22, 2017

BUY
N/A
285
285 $11,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.07B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.